3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
65
Recruiting
61
Active not recruiting
46
Terminated
40
Withdrawn
8
Unknown
8
Not yet recruiting
5
Suspended
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Conditions
Melanoma
2
Lung Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Lymphoma
1
Histiocytic Sarcoma
1
Head and Neck Neoplasms
1
Dendritic Cell Sarcoma, Interdigitating
1
Dendritic Cell Sarcoma, Follicular
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Brain Neoplasms
1
Interventions
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
Squamous Cell Carcinoma of Head and Neck
×
pembrolizumab
×
Clear all
NCT04266730
2026-04-23
PANDA-VAC
UNC Lineberger Comprehensive Cancer Center
Phase 1
Suspended
6 enrolled